The CAD Market in the United States is Forecast to Reach US$376 Million worth 4,200 Units by 2020

Rising Prevalence of Cancer and Focus on Early Diagnosis to Drive the CAD Market, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive report on Computer Aided Detection (CAD). The CAD market in the United States is forecast to reach US$376 million worth 4,200 units by 2020, driven by rising cancer incidence, focus on early diagnosis, and proven efficiency in breast cancer detection.

The dramatic rise in the use of digital imaging modalities is resulting in significant increases in the volume of image-data generated. CAD technology enables accurate analysis of clinical imaging data with minimal detection errors. Computers and relevant software have been playing pivotal roles in the acquisition, storage, and distribution of images captured from imaging modalities (such as X-ray, Ultrasound diagnostics, and MRI).The use of CAD is proven to increase cancer detection in early stages. Advancements in digital imaging techniques are paving the way for enhanced adoption of CAD in imaging. Major advancements include ease of integration with imaging modalities from multiple vendors, improved display aspects, manipulability of images, image viewing, and management speed. Efforts are underway to expand the utility of CAD technology to 3D imaging through tomosynthesis. A number of vendors are developing tomosynthesis CAD products for analysis of 3D data sets. 

Breast cancer detection continues to dominate the market, supported by the rising use of CAD in conjunction with ultrasound, mammography, and MRI. Technology advancements are encouraging the use of the technology in colon, lung, prostrate, and liver cancer diagnosis. Use of CAD in lung and colon cancer detection is gaining momentum, driven by the availability of new innovative products. Despite gaining popularity over the years, CAD continues to remain the second choice among radiologists after mammography. However, with the inclusion of patient context element, adoption is poised grow in the coming years. Patient context requires the integration of vital patient information, such as medical history, and details of prior diagnoses and mammograms.

As stated by the new market research report on Computer Aided Detection (CAD), the United States represents the largest market worldwide. The country is also projected to be the fastest growing market with a compounded annual growth rate of 9.6% over the analysis period. The US FDA’s release of final guidance providing clarity to manufacturers on clinical study requirements, and approval of CAD devices and software, is expected to foster the development of new products in the coming years. Meanwhile, the focus on early detection is expected to increase the significance of CAD technology in Europe.

Major players covered in the report include EDDA Technology Inc., Hologic Inc., iCAD Inc., Invivo Corp., Merge Healthcare Inc., Riverain Technologies, Salient Imaging Inc., Siemens Healthcare, and VuCOMP Inc., among others.

The research report titled “Computer Aided Detection (CAD): A US and European Market Report” announced by Global Industry Analysts Inc., provides a comprehensive review of trends, growth drivers, restraints, market share, size and demand projections and forecasts. Major geographic regions covered include the United States and Europe. Application segments analyzed in the report include Breast, Chest, and Others. The report also offers coverage on mergers, acquisitions, product launches and other strategic industry activities of major global and regional players.